Evidence map›Paper›PMID 33328877›Full record

ArticleFrontiers in neuroscience2020

Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer's Disease.

Jill K Morris, Casey S John, Zachary D Green, Heather M Wilkins, Xiaowan Wang, Ashwini Kamat, Russell S Swerdlow, Eric D Vidoni, Melissa E Petersen, Sid E O'Bryant and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Article
  3. Current Perspectives: Obesity and Neurodegeneration - Links and Risks.Degenerative neurological and neuromuscular disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jill K MorrisDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Casey S JohnDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Zachary D GreenDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Heather M WilkinsDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Xiaowan WangDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Ashwini KamatUniversity of Kansas Alzheimer's Disease Center, Kansas City, KS, United States.
Russell S SwerdlowDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Eric D VidoniDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Melissa E PetersenDepartment of Family Medicine, University of North Texas Health Science Center, Fort Worth, TX, United States.
Sid E O'BryantInstitute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, United states.
Robyn A HoneaDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
Jeffrey M BurnsDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.
University of Kansas · USUniversity of Kansas Medical Center · USUniversity of North Texas Health Science Center · US

Funding

University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NEWELL, KATHY L · 2011 to 2020
$16.6M
Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican AmericansR01AG054073 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI O'BRYANT, SID E, TOGA, ARTHUR W · 2017 to 2021
$12.6M
Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Acute exercise and the cerebral metabolic response in aging and Alzheimer's DiseaseR01AG062548 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2020 to 2024
$2.4M
Relationship of Energetics and Cognitive Trajectory’R00AG050490 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2018 to 2020
$747k
Metabolic hormones, aging, and Alzheimer's DiseaseK99AG050490 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2016 to 2017
$268k
NIA NIH HHS K99 AG050490NIA NIH HHS P30 AG035982NIA NIH HHS R00 AG050490NIA NIH HHS R01 AG054073NIA NIH HHS R01 AG062548NICHD NIH HHS U54 HD090216
6 · The paper itself

Abstract

backgroundIndividuals with Alzheimer's Disease (AD) are often characterized by systemic markers of insulin resistance; however, the broader effects of AD on other relevant metabolic hormones, such as incretins that affect insulin secretion and food intake, remains less clear.

methodsHere, we leveraged a physiologically relevant meal tolerance test to assess diagnostic differences in these metabolic responses in cognitively healthy older adults (CH;

resultsThe meal-stimulated response of glucose, insulin, and peptide tyrosine tyrosine (PYY) was significantly greater in individuals with AD as compared to CH. Voxel-based morphometry revealed negative relationships between brain volume and the meal-stimulated response of insulin, C-Peptide, and glucose-dependent insulinotropic polypeptide (GIP) in primarily parietal brain regions.

conclusionOur findings are consistent with prior work that shows differences in metabolic regulation in AD and relationships with cognition and brain structure.

Indexed as

Alzheimer’s diseaseglucoseinsulininsulin resistanceMRIneuroimagingPYYvoxel based morphometry

Identifiers

PMID33328877
PMCPMC7734152
OpenAlexW3107230707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.